Ultrasound
Late-stage clinical developmentRecent clinical, regulatory, research and industry developments relating to this drug.
Monitoring Neoadjuvant Chemotherapy of Breast Cancer Using 3D Subharmonic Aided Pressure Estimation
Light and ultrasound reveal renewable routes to compounds for pharmaceutical research
Feasibility and efficacy of ultrasound-guided block of the saphenous nerve in the adductor canal.
Anatomic basis to the ultrasound-guided approach for saphenous nerve blockade.
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Late-stage studies
Phase III+ trials still open or recently active — where late-stage evidence is being generated.
Recent completions
Trials that read out recently, adding to the completed evidence base.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes2
Journals, researchers & institutions
- Regional anesthesia and pain medicine2
- Benninger B1
- Brull R1
- Chan VW1
- Duggan E1
- Horn JL1
- Manickam B1
- Perlas A1
- Pitsch T1
- Oregon Health and Science University1
- Toronto Western Hospital1
- RxNorm (U.S. National Library of Medicine) — drug identity
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials